Thermon Group Holdings Inc (THR)

20.42
NYSE : Industrial Goods
Prev Close 20.30
Day Low/High 20.01 / 20.46
52 Wk Low/High 13.97 / 24.46
Avg Volume 114.50K
Exchange NYSE
Shares Outstanding 32.23M
Market Cap 654.32M
EPS 0.70
P/E Ratio 28.59
Div & Yield N.A. (N.A)

Latest News

Commit To Purchase Thermon Group Holdings At $17.50, Earn 10.3% Annualized Using Options

Commit To Purchase Thermon Group Holdings At $17.50, Earn 10.3% Annualized Using Options

Investors considering a purchase of Thermon Group Holdings Inc stock, but tentative about paying the going market price of $18.99/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the November put at the $17.50 strike, which has a bid at the time of this writing of $1.05.

Thermon Group Holdings is Now Oversold (THR)

Thermon Group Holdings is Now Oversold (THR)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

IIROC Trading Halt - THR

IIROC Trading Halt - THR

Thermon Group Holdings Enters Oversold Territory (THR)

Thermon Group Holdings Enters Oversold Territory (THR)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Thermon Group Holdings is Now Oversold (THR)

Thermon Group Holdings is Now Oversold (THR)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: None Downgrades: BWINB, CBS, CGI, DCUA, DCUB, IPXL, KING, KTWO, THR Initiations: LOCO Read on to get TheStreet Quant Ratings' detailed report:

Insider Trading Alert - THR, CNBKA And N Traded By Insiders

Insider Trading Alert - THR, CNBKA And N Traded By Insiders

Stocks with insider trader activity include THR, CNBKA and N

ThromboGenics Business Update H1 2015

ThromboGenics Business Update H1 2015

Oversold Conditions For Thermon Group Holdings (THR)

Oversold Conditions For Thermon Group Holdings (THR)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Insider Trading Alert - LAYN, THR And N Traded By Insiders

Insider Trading Alert - LAYN, THR And N Traded By Insiders

Stocks with insider trader activity include LAYN, THR and N

Insider Trading Alert - LAYN, THR And N Traded By Insiders

Insider Trading Alert - LAYN, THR And N Traded By Insiders

Stocks with insider trader activity include LAYN, THR and N

Insider Trading Alert - ENLC, THR And CNBKA Traded By Insiders

Insider Trading Alert - ENLC, THR And CNBKA Traded By Insiders

Stocks with insider trader activity include ENLC, THR and CNBKA

ThromboGenics Q1 2015 Business Update

ThromboGenics Q1 2015 Business Update

ThromboGenics And VIB Launch New Oncology Company

ThromboGenics And VIB Launch New Oncology Company

Oncurious NV to develop TB-403 for Pediatric Brain Tumors